Stay updated on Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check13 days agoChange DetectedAn NIH notice points visitors to transition updates and FAQs, explaining that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference0.4%

- Check20 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check27 days agoChange DetectedA new study-record version was added, reflecting updates to the study status and contact/location information. The page’s displayed revision also advanced to v3.7.1.SummaryDifference0.3%

- Check48 days agoChange DetectedThe footer now displays Revision: v3.7.0, and the contact information link text has been updated from 'Find Contact Information' to 'Find contact information' to reflect a cosmetic UI/typography update on the page.SummaryDifference0.1%

- Check55 days agoChange DetectedA new 'Study Status' entry is added to the history on 2026-09-08, and the history count is updated to 46 on 2026-09-04; an older entry from 2026-08-10 is removed.SummaryDifference0.2%

Stay in the know with updates to Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.